US2022133151A1PendingUtilityA1
Body structure imaging
Est. expiryJan 24, 2033(~6.5 yrs left)· nominal 20-yr term from priority
Inventors:Shlomo Ben-Haim
G06T 12/00A61B 6/506A61B 5/055A61B 2018/00434G06T 2207/10104A61B 5/0035A61B 5/4893A61B 18/1492A61B 5/72G06T 7/11G06T 2207/30048A61B 5/4041A61B 6/481G06T 7/174A61B 8/085A61B 6/032A61B 6/037A61B 2018/00577A61B 5/004A61B 5/7425A61B 5/4035G06T 2200/04G06T 11/60G06T 2207/10081A61B 2018/00642G06T 2207/30024A61B 5/0044A61B 6/5235G06T 7/0012A61B 6/5247G06T 2207/10136G06T 2207/10076G06T 11/003
72
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A method of imaging nervous tissue, comprising acquiring functional imaging modality data from a functional imaging modality which images an intrabody volume of a patient having a body part, the patient having been injected with an imaging agent having a nervous tissue uptake by an autonomic nervous system (ANS); and locating the nervous tissue in the intrabody volume based on the functional imaging modality data.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A method of imaging nervous tissue, comprising:
acquiring functional imaging modality data from a functional imaging modality which images an intrabody volume of a patient having a body part, the patient having been injected with an imaging agent having a nervous tissue uptake by an autonomic nervous system (ANS); and locating the nervous tissue in the intrabody volume based on the functional imaging modality data.
2 . The method of claim 1 , further comprising generating an image of the ANS based on the located nervous tissue with activity levels.
3 . The method of claim 2 , wherein the image indicates activity levels of the located nerve tissue.
4 . The method of claim 1 , further comprising setting up a system for treatment of the located nervous tissue to treat disease based on improper activity of the located nervous tissue.
5 . The method of claim 1 , further comprising acquiring anatomical imaging modality data from an anatomical image modality which images an intrabody volume of the patient containing the body part, and wherein locating comprises locating the nervous tissue in the intrabody volume of the heart based on the functional imaging modality data and the anatomical imaging modality data.
6 . The method of claim 5 , further comprising positioning the located nervous tissue on the anatomical imaging modality data.
7 . The method of claim 6 , wherein the anatomical imaging modality data is acquired in real time during a treatment procedure, the locating is performed before and/or in real time during the treatment procedure, and the location of the nervous tissue is presented to an operator performing the treatment procedure.
8 . The method of claim 1 , wherein locating comprises locating at least one ganglionic plexus (GP) of the ANS, with a size of between 1 and 20 mm in maximal diameter.
9 . The method of claim 1 , wherein locating comprises locating at least two ganglionic plexus (GP) of the ANS, with a size of between 1 and 20 mm in maximal diameter.
10 . The method of claim 1 , further comprising generating an ANS map comprising a distribution and/or activity of one or both of ANS synapses and GPs, and providing the ANS map for display.
11 . The method of claim 10 , further comprising overlaying the ANS map with an image representation of an organ containing the nervous tissue.
12 . The method of claim 1 , further comprising diagnosing the patient, the diagnosing comprising estimating an effect of the ANS on an organ based on one or both of activity and distribution of synapses and/or ganglions with respect to the organ.
13 . The method of claim 1 , further comprising stimulating the ANS in conjunction with an imaging thereof and distinguishing between afferent and efferent activity based on the stimulation and the imaging.
14 . The method of claim 1 , further comprising estimating an effect or change in effect and/or response of an autonomous nervous system and/or an organ based on one or both of activity and distribution of synapses and/or ganglions with respect to the organ, before, during and/or after the treatment.
15 . The method of claim 1 , further comprising assigning the functional imaging modality data to spatial locations according to a model of a structure of an organ identifying the nervous tissue synapses and/or innervations based on data associated with the organ.
16 . The method of claim 1 , further comprising providing a mapping function which maps for at least one region in the intrabody volume of a reference kinetic behavior, and applying the mapping function on the functional data to locate the nervous tissue in the intrabody volume.
17 . The method of claim 1 , further comprising stimulating a nervous tissue in an intrabody volume of a patient to trigger a nervous response associated with a reference uptake value, acquiring, during the nervous response, functional data from the functional modality which images the intrabody volume, and localizing the nervous tissue in the intrabody volume according to the reference uptake value.
18 . The method of claim 1 , further comprising acquiring anatomical data from an anatomical imaging modality which images the intrabody volume of the patient and localizing the target nervous tissue in the intrabody volume based on both the functional data and the anatomical data.
19 . The method of claim 1 , wherein localizing comprises identifying at least one region of interest (ROI) in an intrabody area according to a match with a reference value representing a reference uptake rate of an organ.
20 . The method of claim 1 , wherein localizing comprises filtering at least part of a representation of the intrabody volume in the functional data based on a match with a reference value.Join the waitlist — get patent alerts
Track US2022133151A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.